Researchers find Coca-Cola paid scientists to downplay how their drinks fuelled the obesity crisis
August 5, 2020Research and Development, Sales and Marketing Coca-Cola, Coke
Researchers have found that Coca-Cola paid an organization of scientists to downplay how the sugary drinks they sell fuelled the …
Medipharma appoints Former President of Janssen Chris Halyk to its Board of Directors
August 4, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Medipharma has appointed Chris Halyk, the former President of Janssen, to its Board of Directors. This is the third appointment …
VelosBio reveals new Chief Financial Officer
August 4, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing VelosBio, appointment
Dr Enoch Kariuki has been named as the new Chief Financial Officer at biopharma firm VelosBio, where he will assume …
Russia claims it will start mass immunisation with a COVID-19 vaccine from October
August 4, 2020Manufacturing and Production Russia, Vaccine, putin
The Russian government is claiming it will start production of a viable coronavirus vaccine candidate next month and begin the …
Sanofi indicted on manslaughter charges over its epilepsy drug Depakine
August 4, 2020Manufacturing and Production Sanofi, Vaccine
Sanofi is being investigated for manslaughter in France over the deaths of four babies whose mothers took its anti-epilepsy medication …
UK Government tells medicine suppliers to stockpile drugs for no-deal Brexit despite coronavirus concerns
August 4, 2020Manufacturing and Production UK, brexit, coronavirus
The British government has contacted medicine suppliers urging them to stockpile drugs for a possible no-deal Brexit, despite the pressure …
Novartis’ CAR T therapy Kymriah nails main goal in follicular lymphoma
August 4, 2020Manufacturing and Production, Research and Development CAR-T therapy, Cancer, Kymriah, Novartis, car t therapy
Novartis is celebrating the success of its one-time CAR T therapy Kymriah (tisagenlecleucel) in patients with relapsed or refractory (r/r) …
FDA expands approval for Janssen’s Spravato nasal spray to cover major depressive disorder with suicidal ideation
August 4, 2020Manufacturing and Production FDA Janssen, Spravato, depression
The FDA has moved to expand the existing approval of Janssen’s Spravato (esketamine) CIII nasal spray to include treatment of symptoms …
CAR T cell therapy is revolutionising cancer treatment, but at what cost?
August 3, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature
CAR T cell therapy is one of the latest innovations in gene therapy. The process is primarily used to treat …
Novartis’ Cosentyx gets European go-ahead in paediatric plaque psoriasis
August 3, 2020Sales and Marketing Cosentyx, Europe, Novartis, pharma, psoriasis
Novartis’ interleukin-17A (IL-17A) inhibitor Cosentyx (secukinumab) has chalked up approval from the European Commission (EC) for the treatment of patients …
EU agrees deal with Sanofi for COVID-19 vaccine supply
August 3, 2020Sales and Marketing COVID, COVID-19, coronavirus
The EU has reached an agreement with Sanofi for 300 million doses of their COVID-19 vaccine candidate which will allow …
England to start using two new 90-minute COVID-19 tests in preparation for the winter
August 3, 2020Sales and Marketing COVID-19, coronavirus
Two new coronavirus tests are set to be made available throughout England that are significantly faster than most already in …
FDA gives nod for Monjuvi combo for second-line relapsed or refractory diffuse large B-cell lymphoma
August 3, 2020Sales and Marketing FDA, Incyte, Monjuvi, morphosys, pharma
The FDA has awarded MorphoSys and Incyte US approval for their Fc-modified cytolytic CD19-targeting monoclonal antibody Monjuvi (tafasitamab-cxix), when used …
FDA approves CBD treatment for seizures associated with tuberous sclerosis complex
August 3, 2020Sales and Marketing CBD, tsc
The FDA has approved Epidiolex (cannabidiol) as a treatment for seizures associated with tuberous sclerosis complex (TSC) in patients over …
US Government commits $2.1bn to GSK and Sanofi’s COVID-19 vaccine candidate
July 31, 2020Medical Communications, Research and Development COVID-19, GSK, Sanofi, US, Vaccine
The US Government has announced additional funding into Sanofi and GlaxSmithKline’s efforts to develop a recombinant protein-based vaccine to the …
Top Ten most popular articles on Pharmafile.com this week
July 31, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Roche, UK government, Vaccine, lilly, pharma, top 10
Another week dominated by COVID-19. Among our most popular stories this week, Celltrion’s infliximab biosimilar Remsima has scored approval for …
Japan reserves 120m doses of BioNTech’s COVID-19 vaccine
July 31, 2020Manufacturing and Production, Medical Communications BioNTech, COVID-19, Japan, Vaccine, pharma
Japan’s Ministry of Health, Labour and Welfare (MHLW) has sealed a deal with Pfizer and BioNTech to secure 120 million …
FDA expands Stelara indication to cover paediatric plaque psoriasis
July 31, 2020Medical Communications, Sales and Marketing Janssen, Stelara, pharma, plaque psoriasis
Janssen’s IL-12 and IL-23 inhibitor Stelara (ustekinumab) has had its approved indications expanded by the FDA to include the treatment …
Bavencio+Inylta combo approved or Cancer Drugs Fund in advanced renal cell carcinoma
July 31, 2020Medical Communications, Sales and Marketing Merck, NICE, Pfizer, pharma
NICE has revealed that a combination of Merck KGaA’s Bavencio (avelumab) and Pfizer’s Inlyta (axitinib) will be made available as …
Lilly and Boehringer’s Jardiance reduces hospitalisation and CV death risk from heart failure at Phase 3
July 30, 2020Research and Development Boehringer, Eli Lilly, jardiance, pharma
Boehringer Ingelheim and Eli Lilly have announced strong Phase 3 news on their sodium-glucose co-transporter-2 (SGLT2) inhibitor Jardiance (empagliflozin) in …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
